Business Description
PeptiDream is a Japan-based drug discovery company founded in 2006 that uses its proprietary platform to build and screen large libraries of complex peptide compounds, identifying promising drug candidates with high precision across a wide range of disease targets. The company has a broad pipeline spanning oncology, inflammatory conditions, metabolic disorders, and infectious diseases, with several programs already in advanced clinical trials and many more in earlier stages of development. Its work spans both traditional and radioactive drug formats, reflecting a versatile approach to treating serious and hard-to-address medical conditions.
